Adherence to Fluid Intake Recommendations in Kidney Stone Patients

NCT ID: NCT05329389

Last Updated: 2023-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

135 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2024-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The cumulative risk of stone recurrence rate is up to 14% at 1 year, 35% at 5 years, and 52% at 10 years. Low urine volume caused by insufficient fluid consumption is one of the most crucial risk factors for kidney stone formation. According to the guidelines, a copious fluid intake to maintain a urine volume of at least 2.0 to 2.5 L/24 h is recommended for most kidney stone formers. Patients often find it difficult to follow the recommendations in fluid intake, which leads to stone recurrence. Therefore, there is a need to improve patient compliance and adherence to following the instructions on keeping water balance. For this purpose we developed a mixed educational program including two parts. The first is the mobile application called "StoneMD: Kidney Stones". The second is the "School for Patients" with kidney stones, which is responsible for the stone clinic effect.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to test the hypothesis that using mixed educational program additionally to standard recommendations in patients after the first stone surgery episode helps to achieve better adherence to daily fluid intake recommendations than the using standard recommendations alone given at the day of discharge.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urolithiasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

In case of presence/absence of inclusion/exclusion criteria and written informed consent will be obtained, patients will be randomized in a 1:1:1 ratio according to the list of randomized blocks using a computer generator. Patients will be randomized at the last available moment in order to minimize bias.
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

StoneMD

Patients will receive standard recommendations of keeping diuresis at the level of 2.5 l/day and to use the StoneMD application on their smartphones after the surgery. Patients will use the section "Water balance" and follow the instructions during the 12 month after the surgery.

Group Type EXPERIMENTAL

StoneMD

Intervention Type DEVICE

StoneMD - is an app from App Store (for iOS) or Google Play (for Android).

Standard recommendation

Intervention Type BEHAVIORAL

Only fluid balance recommendations given at the day of discharge.

StoneMD & Schools of Patients

Patients will receive standard recommendations of keeping diuresis at the level of 2.5 l/day and and recommendations to use the StoneMD application on their smartphones after the surgery. Patients will use the section "Water balance" and follow the instructions during the 12 month after the surgery. Additionally, patients will visit schools during a following year. Patients receive 4 consultations (one per 3 month).

Group Type EXPERIMENTAL

StoneMD

Intervention Type DEVICE

StoneMD - is an app from App Store (for iOS) or Google Play (for Android).

Schools of Patients

Intervention Type BEHAVIORAL

The "Schools for Patients" with Urolithiasis is an online course for patients with urinary stone disease.

Standard recommendation

Intervention Type BEHAVIORAL

Only fluid balance recommendations given at the day of discharge.

Recommendations only

Only fluid balance recommendations given at the day of discharge. Patients will receive recommendations of keeping diuresis at the level of 2.5 l/day after the surgery

Group Type ACTIVE_COMPARATOR

Standard recommendation

Intervention Type BEHAVIORAL

Only fluid balance recommendations given at the day of discharge.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

StoneMD

StoneMD - is an app from App Store (for iOS) or Google Play (for Android).

Intervention Type DEVICE

Schools of Patients

The "Schools for Patients" with Urolithiasis is an online course for patients with urinary stone disease.

Intervention Type BEHAVIORAL

Standard recommendation

Only fluid balance recommendations given at the day of discharge.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Low risk recurrence group patients;
* Patients after the first stone surgery;

Exclusion Criteria

* Recurrent cases of stone formation;
* Patients, who do not have smartphones;
* Patients, who can't visit "Schools for Patients" with kidney stone disease;
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gadzhiev Nariman

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gadzhiev Nariman

PhD, Urologist, Deputy Medical Director of Saint-Petersburg State University Clinic

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nariman Gadzhiev, PhD

Role: PRINCIPAL_INVESTIGATOR

Deputy Medical Director

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SBPSU

Saint Petersburg, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vitalii Gelig, MD

Role: CONTACT

+7 905 200-83-68

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vitalii Gelig

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989 Dec 15;111(12):1006-9. doi: 10.7326/0003-4819-111-12-1006.

Reference Type BACKGROUND
PMID: 2688503 (View on PubMed)

Siener R, Hesse A. Fluid intake and epidemiology of urolithiasis. Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S47-51. doi: 10.1038/sj.ejcn.1601901.

Reference Type BACKGROUND
PMID: 14681713 (View on PubMed)

Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petrik A, Turk C. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20.

Reference Type BACKGROUND
PMID: 25454613 (View on PubMed)

Becker B, Gadzhiev N, Popiolek M, Gross AJ, Netsch C. [A mobile app for patients suffering from kidney stones]. Urologe A. 2018 May;57(5):577-582. doi: 10.1007/s00120-018-0652-0. German.

Reference Type BACKGROUND
PMID: 29713752 (View on PubMed)

Gadjiev N.K., Gorelov D.S., Akopyan G.N., Gelig V.A., Ivanov A.O., Petrov S.B., Kryukova N.U., Reva S.A., Ponomareva Yu.A., Al-Shukri A.S., Mischenko A.A., Kogai M.A., Vasiliev V.N., Chernysheva D.Yu., Obidnyak V.M., Makar'in V.A., Pisarev A.V., Zakuckij A.N., Kuzmin I.V., Amdiy R.E., Korneyev I.A., Al-Shukri S.H. "Schools for Patients" with Urolithiasis and Prostatic Diseases. Vestnik Urologii. 2020;8(1):110-120. (In Russ.) https://doi.org/10.21886/2308-6424-2020-8-1-110-120

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

StoneMD_Schools_for_patients

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Potassium Citrate and Crystal Light Lemonade
NCT05389995 ACTIVE_NOT_RECRUITING NA
Oxalate and Citrate
NCT05334979 RECRUITING NA
Kidney Stone Calculator
NCT05707988 UNKNOWN